Addus HomeCare Corporation $ADUS Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lowered its holdings in Addus HomeCare Corporation (NASDAQ:ADUS) by 2.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 160,789 shares of the company’s stock after selling 3,329 shares during the quarter. Bank of New York Mellon Corp owned 0.87% of Addus HomeCare worth $18,521,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Nuveen LLC purchased a new stake in Addus HomeCare in the first quarter valued at $16,155,000. Wellington Management Group LLP boosted its stake in shares of Addus HomeCare by 25.8% in the first quarter. Wellington Management Group LLP now owns 471,935 shares of the company’s stock worth $46,670,000 after buying an additional 96,823 shares during the last quarter. Allianz Asset Management GmbH grew its holdings in Addus HomeCare by 1,229.4% during the first quarter. Allianz Asset Management GmbH now owns 100,898 shares of the company’s stock worth $9,978,000 after acquiring an additional 93,308 shares during the period. Leeward Investments LLC MA purchased a new position in Addus HomeCare during the second quarter valued at approximately $9,152,000. Finally, Invesco Ltd. raised its position in Addus HomeCare by 19.8% during the first quarter. Invesco Ltd. now owns 414,705 shares of the company’s stock valued at $41,010,000 after acquiring an additional 68,585 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

ADUS opened at $109.07 on Monday. The firm’s fifty day simple moving average is $115.15 and its two-hundred day simple moving average is $113.15. Addus HomeCare Corporation has a 52-week low of $88.96 and a 52-week high of $136.72. The company has a market cap of $2.02 billion, a price-to-earnings ratio of 24.08, a PEG ratio of 1.87 and a beta of 0.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.53 by $0.03. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The firm had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. During the same quarter in the prior year, the firm earned $1.30 EPS. The company’s revenue for the quarter was up 25.0% on a year-over-year basis. Equities analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have commented on ADUS. Barclays upped their price objective on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 4th. Cowen restated a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Stephens reissued an “overweight” rating and set a $140.00 target price on shares of Addus HomeCare in a research note on Wednesday, September 3rd. Finally, UBS Group assumed coverage on Addus HomeCare in a research report on Tuesday, September 2nd. They set a “buy” rating and a $145.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $137.11.

Insider Buying and Selling at Addus HomeCare

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the transaction, the director owned 5,067 shares in the company, valued at $582,350.31. This trade represents a 23.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total value of $2,873,750.00. Following the sale, the chief executive officer owned 166,461 shares of the company’s stock, valued at $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 34,310 shares of company stock valued at $3,958,375 over the last quarter. 4.50% of the stock is currently owned by insiders.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.